Pharma Pulse 10/1/24: Venture Mega-Rounds Return to Biotech, Disposing of Non-Core Assets & more

Disposing of Non-Core Assets with Minimal Disruption

In this part of his Pharmaceutical Executive video interview, Jonathan Scheinberg, of the Northeast Science and Technology Center, discusses strategies companies employ to effectively identify and dispose of non-core assets while minimizing disruption to their operations.

Pandemic-Related Hospital Caseload Strain Attributes to Portion of COVID-19 Deaths

There was a detrimental relationship between COVID-19 caseload and mortality observed across multiple types of hospitals.

Venture Mega-Rounds Return to Biotech

The number of deals for $100 million or more have put biotech on pace to come close to full-year 2021’s record total, industry data show.

ImmunoTek Celebrates International Plasma Awareness Week

ImmunoTek Bio Centers is excited to announce their participation in International Plasma Awareness Week (IPAW) from October 7-11, 2024. The community is invited to experience Plasma Mania happening during this special week in both divisions of ImmunoTek Bio Centers – ImmunoTek Plasma and Freedom Plasma. The week-long celebration is dedicated to raising awareness about the vital role plasma donations play in saving lives and improving patient outcomes worldwide.

Veeva Systems on LinkedIn

As part of the Veeva AI Partner Program, ODAIA Engagement Intelligence integrates with Veeva CRM, and soon in Vault CRM, to enable AI-driven insights for reps. Learn more in Pharmaceutical Commerce Magazine about how Veeva and ODAIA are giving a more comprehensive view of HCPs to drive targeted, relevant engagement. https://lnkd.in/eMYdeNSJ

#lifesciences #CRM #HCPengagement

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs